Equity Overview
Price & Market Data
Price: $0.321
Daily Change: -$0.0037 / 1.15%
Range: $0.292 - $0.398
Market Cap: $17,284,622
Volume: 496,454
Performance Metrics
1 Week: 34.55%
1 Month: -23.38%
3 Months: -74.14%
6 Months: -97.04%
1 Year: -96.86%
YTD: -81.51%
Company Details
Employees: 4
Sector: Finance
Industry: Financial conglomerates
Country: United States
Details
Abpro Holdings, Inc., a biotechnology company, provides antibody therapeutics for cancer related issues. Its platform DiversImmune addresses the antibody therapeutics. The company's product candidates include ABP-102 for the treatment of breast and gastric cancer; and ABP-110 for the treatment of liver cancer. It also offers ABP-105 for the treatment of gastric cancer and ABP 201 for vascular diseases of the eye and diabetic macular edema. Abpro Holdings, Inc. was incorporated in 2004 and is based in Woburn, Massachusetts.